.svg){kind=small}
Sep-2025
Sales
Trend
6-Month
Product Count
SKUs
Overview
Market Insights Snapshot
Stigma Grow has demonstrated a strong presence in the Alberta market, particularly in the Capsules category, where it consistently ranked third from June to September 2025. Despite this steady ranking, sales have shown a downward trend, with a notable decrease from June to August, before slightly rebounding in September. Conversely, in the Concentrates category, the brand experienced some fluctuations in its rankings, moving from 16th in June to 12th in August, before settling at 14th in September. This indicates a dynamic market position in Concentrates, supported by a significant sales increase in August, suggesting a potential area of growth for the brand.
In British Columbia, Stigma Grow's performance in the Concentrates category mirrored some of the trends seen in Alberta, with a gradual improvement in rankings from 19th in June to 14th by September. This upward movement highlights a strengthening position in the market, although the sales figures suggest a slight decline from August to September. Meanwhile, in Ontario, Stigma Grow maintained a relatively stable presence in the Capsules category, consistently ranking around the 10th position. However, it's noteworthy that the brand only entered the top 30 in the Concentrates category in August and September, ranking 48th and 52nd, respectively, indicating room for improvement in this category in Ontario.
Competitive Landscape
In the Alberta concentrates market, Stigma Grow has shown a dynamic performance over the months from June to September 2025. Starting at the 16th position in June, Stigma Grow experienced a slight dip to 18th in July but rebounded to 12th in August, before settling at 14th in September. This fluctuation indicates a competitive landscape where Stigma Grow is actively vying for a stronger foothold. Notably, Astro Lab consistently maintained a higher rank, though it saw a decline from 6th in June to 12th by September, suggesting potential vulnerabilities that Stigma Grow could capitalize on. Meanwhile, The Goo! also displayed a downward trend, slipping from 5th to 11th, which might indicate a shift in consumer preferences or market dynamics. On the other hand, Virtue Cannabis showed an upward trajectory, improving from 24th in June to 16th in September, highlighting the competitive pressure on Stigma Grow to maintain and improve its market position. Overall, Stigma Grow's ability to climb back to 12th in August demonstrates its potential to leverage market opportunities and enhance its sales performance amidst a challenging competitive environment.
Notable Products
In September 2025, the top-performing product for Stigma Grow was Phoenix Tears RSO (1g) in the Concentrates category, maintaining its first-place rank from August with sales of 4298. Indica RSO Capsules 25-Pack (250mg) held steady in second place, following a consistent ranking since July. CBD Softgels 15-Pack (750mg CBD) remained in third position, showing stable performance across the months. Phoenix Tears Honey Oil (1g) improved its ranking to fourth place from fifth, indicating a positive sales trend. Phoenix Tears Resin (1g) ranked fifth, maintaining its position from August, despite not being ranked in July.
Top Selling Cannabis Brands
Data for this report comes from real-time sales reporting by participating cannabis retailers via their point-of-sale systems, which are linked up with Headset’s business intelligence software. Headset’s data is very reliable, as it comes digitally direct from our partner retailers. However, the potential does exist for misreporting in the instance of duplicates, incorrectly classified products, inaccurate entry of products into point-of-sale systems, or even simple human error at the point of purchase. Thus, there is a slight margin of error to consider. Brands listed on this page are ranked in the top twenty within the market and product category by total retail sales volume.
